View Single Post
Old 01-05-2021, 03:24 PM   #1
Nguyen
Senior Member
 
Join Date: Nov 2005
Posts: 324
ARX788: A potential new treatment after T-DM1, Enhertu.

For some reason I can not post in "Articles of interest" section.

https://www.targetedonc.com/view/fda...BnbWFpbC5jb20=

http://ambrx.com/ambrx-presents-phas...cer-symposium/

ARX788, a Site-specific anti-HER2 Antibody Drug Conjugate, Demonstrates Potent and Selective Activity in HER2 Low and T-DM1 Resistant Breast and Gastric Cancers

https://sci-hub.se/https://mct.aacrj....full-text.pdf
Nguyen is offline   Reply With Quote